TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
FrostPharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
183,010
|
139,364
|
79,206 |
Financial expenses |
2,958
|
2,118
|
1,914 |
Earnings before taxes |
14,005
|
28,310
|
-5,570 |
EBITDA |
18,301
|
31,106
|
-3,642 |
Total assets |
127,197
|
100,238
|
60,925 |
Current assets |
119,234
|
91,951
|
58,362 |
Current liabilities |
43,730
|
67,724
|
54,295 |
Equity capital |
42,154
|
31,244
|
6,630 |
- share capital |
60
|
58
![]() |
58 |
Employees (average) |
15
|
10
|
8 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
33.1%
|
31.2%
|
10.9% |
Turnover per employee |
12,201
|
13,936
|
9,901 |
Profit as a percentage of turnover |
7.7%
|
20.3%
|
-7.0% |
Return on assets (ROA) |
13.3%
|
30.4%
|
-6.0% |
Current ratio |
272.7%
|
135.8%
|
107.5% |
Return on equity (ROE) |
33.2%
|
90.6%
|
-84.0% |
Change turnover |
43,646
|
60,158
|
-83,995 |
Change turnover % |
31%
|
76%
|
-51% |
Chg. No. of employees |
5
|
2
|
3 |
Chg. No. of employees % |
50%
|
25%
|
60% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.